Canada approves first generic Ozempic as competition intensifies in GLP-1 market

Health Canada has approved the first generic version of Novo Nordisk’s blockbuster diabetes drug Ozempic, developed by India’s Dr. Reddy’s Laboratories, according …

German cabinet approves health insurance reform aimed at reducing costs

Germany’s cabinet on Wednesday approved a draft bill to overhaul the statutory health insurance system, targeting savings of €16.3 billion ($19.08 billion) …

Purdue Pharma sentenced to $5.5 billion in penalties, moving forward opioid settlement process

Purdue Pharma, the maker of OxyContin, was sentenced on Tuesday to pay $5.5 billion in fines and penalties following its 2020 guilty …

Purdue Pharma set to be sentenced, clearing the way for opioid settlement to proceed

Purdue Pharma will be sentenced on Tuesday in New Jersey federal court for deceiving government regulators and paying kickbacks to doctors to …

Eli Lilly and Company to acquire Ajax Therapeutics for up to $2.3 billion in a strategic push into blood cancer treatments

Eli Lilly and Company said on Monday that it will acquire privately held cancer drug developer Ajax Therapeutics for up to $2.3 …

Sun Pharma to Acquire US Drugmaker Organon for $11.75 Billion in India’s Largest Pharma Deal

Sun Pharmaceutical Industries has announced that it will acquire U.S.-based Organon & Co in an all-cash transaction worth around $11.75 billion, including …